THINQ Pharma CRO Ltd.   Report issue

For profit Phase 3
Founded: Mumbai India (1989)

Organization Overview

First Clinical Trial
2016
NCT02635438
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Thinq Pharma-CRO Pte. Ltd.